196 related articles for article (PubMed ID: 22976556)
1. Immune control in the absence of immunodominant epitopes: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.
Ebert S; Lemmermann NA; Thomas D; Renzaho A; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2012 Nov; 201(4):541-50. PubMed ID: 22976556
[TBL] [Abstract][Full Text] [Related]
2. Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance.
Holtappels R; Lemmermann NA; Podlech J; Ebert S; Reddehase MJ
Front Immunol; 2016; 7():232. PubMed ID: 27379095
[TBL] [Abstract][Full Text] [Related]
3. Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.
Holtappels R; Simon CO; Munks MW; Thomas D; Deegen P; Kühnapfel B; Däubner T; Emde SF; Podlech J; Grzimek NK; Oehrlein-Karpi SA; Hill AB; Reddehase MJ
J Virol; 2008 Jun; 82(12):5781-96. PubMed ID: 18367531
[TBL] [Abstract][Full Text] [Related]
4. Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells.
Fink A; Lemmermann NA; Gillert-Marien D; Thomas D; Freitag K; Böhm V; Wilhelmi V; Reifenberg K; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2012 Nov; 201(4):513-25. PubMed ID: 22961126
[TBL] [Abstract][Full Text] [Related]
5. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool.
Lemmermann NA; Reddehase MJ
Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.
Gergely KM; Podlech J; Becker S; Freitag K; Krauter S; Büscher N; Holtappels R; Plachter B; Reddehase MJ; Lemmermann NAW
Front Immunol; 2021; 12():694588. PubMed ID: 34489940
[TBL] [Abstract][Full Text] [Related]
7. Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting.
Pahl-Seibert MF; Juelch M; Podlech J; Thomas D; Deegen P; Reddehase MJ; Holtappels R
J Virol; 2005 May; 79(9):5400-13. PubMed ID: 15827154
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
[TBL] [Abstract][Full Text] [Related]
9. Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the "Test of Time".
Reddehase MJ; Lemmermann NAW
Viruses; 2018 Dec; 10(12):. PubMed ID: 30563202
[TBL] [Abstract][Full Text] [Related]
10. Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.
Böhm V; Podlech J; Thomas D; Deegen P; Pahl-Seibert MF; Lemmermann NA; Grzimek NK; Oehrlein-Karpi SA; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2008 Jun; 197(2):135-44. PubMed ID: 18340461
[TBL] [Abstract][Full Text] [Related]
11. Parameters determining the efficacy of adoptive CD8 T-cell therapy of cytomegalovirus infection.
Ebert S; Podlech J; Gillert-Marien D; Gergely KM; Büttner JK; Fink A; Freitag K; Thomas D; Reddehase MJ; Holtappels R
Med Microbiol Immunol; 2012 Nov; 201(4):527-39. PubMed ID: 22972232
[TBL] [Abstract][Full Text] [Related]
12. Identification of an atypical CD8 T cell epitope encoded by murine cytomegalovirus ORF-M54 gaining dominance after deletion of the immunodominant antiviral CD8 T cell specificities.
Holtappels R; Lemmermann NA; Thomas D; Renzaho A; Reddehase MJ
Med Microbiol Immunol; 2015 Jun; 204(3):317-26. PubMed ID: 25805564
[TBL] [Abstract][Full Text] [Related]
13. Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones.
Riddell SR; Walter BA; Gilbert MJ; Greenberg PD
Bone Marrow Transplant; 1994; 14 Suppl 4():S78-84. PubMed ID: 7728132
[TBL] [Abstract][Full Text] [Related]
14. Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations.
Malik A; Adland E; Laker L; Kløverpris H; Fardoos R; Roider J; Severinsen MC; Chen F; Riddell L; Edwards A; Buus S; Jooste P; Matthews PC; Goulder PJR
PLoS One; 2017; 12(12):e0189612. PubMed ID: 29232408
[TBL] [Abstract][Full Text] [Related]
15. Immunodominant Cytomegalovirus Epitopes Suppress Subdominant Epitopes in the Generation of High-Avidity CD8 T Cells.
Freitag K; Hamdan S; Reddehase MJ; Holtappels R
Pathogens; 2021 Jul; 10(8):. PubMed ID: 34451420
[TBL] [Abstract][Full Text] [Related]
16. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection.
Gratama JW; van Esser JW; Lamers CH; Tournay C; Löwenberg B; Bolhuis RL; Cornelissen JJ
Blood; 2001 Sep; 98(5):1358-64. PubMed ID: 11520783
[TBL] [Abstract][Full Text] [Related]
17. CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.
Holtappels R; Böhm V; Podlech J; Reddehase MJ
Med Microbiol Immunol; 2008 Jun; 197(2):125-34. PubMed ID: 18343947
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of cytomegalovirus-specific effector CD4+ T cells provides antiviral protection from murine CMV infection.
Jeitziner SM; Walton SM; Torti N; Oxenius A
Eur J Immunol; 2013 Nov; 43(11):2886-95. PubMed ID: 23921569
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells.
Holtappels R; Becker S; Hamdan S; Freitag K; Podlech J; Lemmermann NA; Reddehase MJ
PLoS Pathog; 2023 Nov; 19(11):e1011643. PubMed ID: 37972198
[TBL] [Abstract][Full Text] [Related]
20. Evaluating Human T-Cell Therapy of Cytomegalovirus Organ Disease in HLA-Transgenic Mice.
Thomas S; Klobuch S; Podlech J; Plachter B; Hoffmann P; Renzaho A; Theobald M; Reddehase MJ; Herr W; Lemmermann NA
PLoS Pathog; 2015 Jul; 11(7):e1005049. PubMed ID: 26181057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
